4.8 Article

Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A

Jenny A. Greig et al.

Summary: In a study on hemophilia A mouse model, the minimally effective dose (MED) of gene therapy vector was determined to be 3 x 10(11) GC/kg. Total bilirubin levels increased with higher vector doses, while no significant differences were observed in liver transaminase levels. There were no vector-related gross or histological findings detected.

HUMAN GENE THERAPY (2022)

Article Biotechnology & Applied Microbiology

Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo

Cassandra L. Gorsuch et al.

Summary: This study discovered a highly specific engineered ARCUS nuclease (ARCUS-POL) targeting the hepatitis B virus (HBV) genome, which significantly reduces both the viral covalently closed circular DNA (cccDNA) and hepatitis B surface antigen (HBsAg) in liver cells. Using mouse and non-human primate models, the researchers demonstrated that ARCUS-POL can modify target genes, resulting in a durable reduction of HBsAg levels. These findings provide a theoretical basis for the application of gene editing in HBV treatment.

MOLECULAR THERAPY (2022)

Article Multidisciplinary Sciences

Mitochondrial base editor induces substantial nuclear off-target mutations

Zhixin Lei et al.

Summary: The study reveals that the mitochondrial base editor induces extensive off-target editing in the nuclear genome, highlighting the need to thoroughly define and evaluate the off-target effects of base-editing tools.

NATURE (2022)

Review Genetics & Heredity

Mitochondrial genome engineering coming-of-age

Jose Domingo Barrera-Paez et al.

Summary: Manipulating the mitochondrial genome has been challenging due to its double membranes and lack of a robust recombination system. However, advancements in specific nucleases and gene-editing platforms have allowed researchers to selectively eliminate mutant genes and precisely modify mtDNA in animal cells, representing major progress.

TRENDS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

Kevin A. Strauss et al.

Summary: SPR1NT (NCT03505099) is a Phase III study investigating the efficacy and safety of onasemnogene abeparvovec in presymptomatic children with biallelic SMN1 mutations. The results showed that all 14 infants enrolled in the study were able to sit independently for at least 30 seconds within 18 months and none required permanent ventilation. The treatment was well tolerated and effective for children expected to develop SMA type 1.

NATURE MEDICINE (2022)

Article Engineering, Biomedical

Modulating Mitochondrial DNA Heteroplasmy with Mitochondrially Targeted Endonucleases

Nikita Mikhailov et al.

Summary: Mitochondria are not only the energy factories of eukaryotic cells, but also have various signaling and metabolic functions. Mutations in the mitochondrial genome are a significant contributor to human disease. Modulating the ratio between healthy and mutant mtDNA in patients' cells offers a potential therapeutic option for mtDNA diseases.

ANNALS OF BIOMEDICAL ENGINEERING (2022)

Article Biochemistry & Molecular Biology

Precise and simultaneous quantification of mitochondrial DNA heteroplasmy and copy number by digital PCR

Wendy K. Shoop et al.

Summary: This study developed a new method using a single digital PCR probe to measure mtDNA heteroplasmy, which enables the precise determination of mtDNA copy number and heteroplasmy levels. Testing in human and mouse models showed that this method is faster and more internally controlled compared to other published methods, making it applicable to the detection and quantification of other mixed genetic variations.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biotechnology & Applied Microbiology

Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9

Lili Wang et al.

Summary: The study demonstrates the lasting therapeutic effect of targeted gene disruption through lowering specific protein levels with no obvious adverse changes, providing important data support for the treatment of hypercholesterolemia.

MOLECULAR THERAPY (2021)

Review Biochemistry & Molecular Biology

Tune instead of destroy: How proteolysis keeps OXPHOS in shape

Karolina Szczepanowska et al.

Summary: Mitochondria are highly dynamic and stress-responsive organelles that are regulated by a number of different mechanisms for renewal, maintenance, and removal. Recent findings suggest that mitochondrial proteases have regulatory functions that extend beyond traditional concepts of damage control and stress responses. The spatiotemporal dynamics of the OXPHOS system can be modulated by intrinsic mitochondrial mechanisms, which can substantially contribute to shaping the metabolic status of the cell.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2021)

Article Multidisciplinary Sciences

Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo

Ugne Zekonyte et al.

Summary: This study shows the potential of using mitoARCUS, a mitochondrial-targeted gene editing platform, to specifically eliminate mutant mtDNA with a m.5024C>T mutation in the mt-tRNA(Ala) gene. MitoARCUS was successful in robustly eliminating mutant mtDNA in the liver and skeletal muscle of mice, demonstrating its promise as a powerful tool for the treatment of heteroplasmic mitochondrial DNA mutations.

NATURE COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Strategies for mitochondrial gene editing

Xingbo Yang et al.

Summary: Mitochondria, as the energy powerhouse of cells, have their own unique genome separate from the nuclear genome. Mutations in mitochondrial DNA can lead to diseases and health issues, but editing these genes effectively remains a challenge. Current gene editing technologies have been explored for mitochondrial gene editing, but further research and optimization are needed for their application in this specific area.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Medicine, General & Internal

DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases

U. Zekonyte et al.

JOURNAL OF INTERNAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective

Christopher B. Jackson et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Article Medicine, Research & Experimental

mitoTev-TALE: a monomeric DNA editing enzyme toreduce mutant mitochondrial DNA levels

Claudia V. Pereira et al.

EMBO MOLECULAR MEDICINE (2018)

Article Biotechnology & Applied Microbiology

Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol

Lili Wang et al.

NATURE BIOTECHNOLOGY (2018)

Article Multidisciplinary Sciences

Linear mitochondrial DNA is rapidly degraded by components of the replication machinery

Viktoriya Peeva et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletions

Nadee Nissanka et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation

Sandra R. Bacman et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo

Payam A. Gammage et al.

NATURE MEDICINE (2018)

Article Biotechnology & Applied Microbiology

Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells

Daniel T. MacLeod et al.

MOLECULAR THERAPY (2017)

Article Medicine, General & Internal

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

J. R. Mendell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation

Naoki Yahata et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Selective mitochondrial DNA degradation following double-strand breaks

Amandine Moretton et al.

PLOS ONE (2017)

Article Biochemistry & Molecular Biology

Circumventing the Crabtree Effect: A method to induce lactate consumption and increase oxidative phosphorylation in cell culture

Alexandra I. Mot et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs

Payam A. Gammage et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Medicine, General & Internal

Mitochondrial diseases

Grainne S. Gorman et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Clinical Neurology

Prevalence of Nuclear and Mitochondrial DNA Mutations Related to Adult Mitochondrial Disease

Grainne S. Gorman et al.

ANNALS OF NEUROLOGY (2015)

Article Biochemistry & Molecular Biology

Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing

Pradeep Reddy et al.

Review Endocrinology & Metabolism

MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options

Ayman W. El-Hattab et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Review Genetics & Heredity

The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease

James B. Stewart et al.

NATURE REVIEWS GENETICS (2015)

Article Biochemical Research Methods

The impact of Nucleofection® on the activation state of primary human CD4 T cells

Mingce Zhang et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

Article Biochemistry & Molecular Biology

Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs

Sandra R. Bacman et al.

NATURE MEDICINE (2013)

Article Cell Biology

The Maintenance of Mitochondrial DNA Integrity-Critical Analysis and Update

Mikhail Alexeyev et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Article Biochemistry & Molecular Biology

MELAS: A nationwide prospective cohort study of 96 patients in Japan

Shuichi Yatsuga et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)

Article Biochemistry & Molecular Biology

Non-specific protein-DNA interactions control I-CreI target binding and cleavage

Rafael Molina et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Multidisciplinary Sciences

Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques

Benjamin Dehay et al.

SCIENTIFIC REPORTS (2012)

Review Cell Biology

Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation

Sophia Y. Lunt et al.

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)

Review Cell Biology

The implications of mitochondrial DNA copy number regulation during embryogenesis

Phillippa J. Carling et al.

MITOCHONDRION (2011)

Article Clinical Neurology

Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype

P. Kaufmann et al.

NEUROLOGY (2011)

Article Biotechnology & Applied Microbiology

Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons

Sandra Duque et al.

MOLECULAR THERAPY (2009)

Article Biotechnology & Applied Microbiology

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

Kevin D. Foust et al.

NATURE BIOTECHNOLOGY (2009)

Article Biochemistry & Molecular Biology

A functionally dominant mitochondrial DNA mutation

Sabrina Sacconi et al.

HUMAN MOLECULAR GENETICS (2008)

Article Cell Biology

Population prevalence of the MELAS A3243G mutation

Neil Manwaring et al.

MITOCHONDRION (2007)

Review Clinical Neurology

Pathogenic mitochondrial DNA mutations in protein-coding genes

Lee-Jun C. Wong

MUSCLE & NERVE (2007)

Article Multidisciplinary Sciences

Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase

Michal Minczuk et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease

MP Bayona-Bafaluy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Biochemistry & Molecular Biology

Mitochondrial threshold effects

R Rossignol et al.

BIOCHEMICAL JOURNAL (2003)

Article Biochemistry & Molecular Biology

Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease

S Srivastava et al.

HUMAN MOLECULAR GENETICS (2001)

Review Genetics & Heredity

The genetics and pathology of oxidative phosphorylation

J Smeitink et al.

NATURE REVIEWS GENETICS (2001)

Article Biochemistry & Molecular Biology

Multisite control of the Crabtree effect in ascites hepatoma cells

S Rodríguez-Enríquez et al.

EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)

Review Genetics & Heredity

What regulates mitochondrial DNA copy number in animal cells?

CT Moraes

TRENDS IN GENETICS (2001)